Ozaki, Shoichi <br/><br/>
Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study.  [electronic resource] 

 -  Modern rheumatology  Jun 2012 
 - 394-404 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1439-7609 
<br/><br/><label>Standard No.: </label>10.1007/s10165-011-0525-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--drug therapy<br/>Antibodies, Antineutrophil Cytoplasmic--immunology<br/>Asian People<br/>Cyclophosphamide--therapeutic use<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Japan<br/>Male<br/>Middle Aged<br/>Peroxidase--immunology<br/>Prednisolone--therapeutic use<br/>Remission Induction<br/>Severity of Illness Index<br/>Treatment Outcome